Acaya 100mg Capsule

Small lymphocytic leukemia (SLL), Mantle cell lymphoma (MCL) and Chronic lymphocytic leukemia (CLL)

Every medication has several side effects and it is important to be aware of them before starting any treatment. Common ones are:
● Anemia
● Low blood platelets
● Headache
● Diarrhea
● Neutrophils
● Infections
● Fatigue
● Skin reaction

Acaya 100mg capsule should be taken with food or between foods at the fixed time everyday without avoid missing doses. It should be used only under the prescription of the doctor to ensure safety and effectiveness of the medication. The medication may take several weeks or months to see the results. Inform the doctor if you have any medical history of bleeding disorders, heart or liver disease or if you are taking any other medications or supplements, so they can adjust the treatment effectively.

Acaya 100mg capsule work by blocking or inhibiting Bruton's tyrosine kinase (BTK), a protein that play a vital role in the normal development of B cells that helps the body fight infection by producing antibodies. Therefore, the medication stops the growth of cancer cells and protects the body from further growing cancer in the body.

• Panigrahi, H. N. (2025). A new stability indicating RP-HPLC method for the estimation of Acalabrutinib. Research Journal of Pharmacy and Technology, 18(5), 2349-2355.
• Das, P. P., Banerjee, S., & Bose, S. (2024). Impact of the Asian Spider Flower (Cleome viscosa) on Human Health. In Medicinal Spices and Herbs from India (pp. 133-143). Apple Academic Press.
• Ventosa-Febles, E. (2022). Cleome gynandra (wild spider flower). CABI Compendium. CABI International. doi, 10.
• Wolska-Washer, A., & Robak, T. (2022). Acalabrutinib: a bruton tyrosine kinase inhibitor for the treatment of chronic lymphocytic leukemia. Expert Review of Hematology, 15(3), 183-194.
• Byrd, J. C., Wierda, W. G., Schuh, A., Devereux, S., Chaves, J. M., Brown, J. R., ... & Furman, R. R. (2020). Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results. Blood, 135(15), 1204-1213.